Radiotherapy Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Therapy Type (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Others), By End-User (Hospitals, Ambulatory Surgical Centres, Others), And By Geography - Forecasts From 2021 To 2026

  • Published : Jul 2021
  • Report Code : KSI061610003
  • Pages : 110

The global radiotherapy market was valued at US$8.058 billion in the year 2019 and is estimated to reach up to US$13.861 billion in the year 2026 at a CAGR of 8.06%. The rising number of cancer patients around the world has paved the way for increasing demand for radiotherapy and growing technological advancements in the medical field especially in radiotherapy is another prominent factor for driving the global radiotherapy market growth.

Radiotherapy includes different types of therapy such as External Beam Radiotherapy, Internal Beam Therapy or Brachytherapy, and Systematic Radiotherapy. These therapies are applicable for various types of cancers. More often they are applicable for Prostate cancer, Breast cancer, lungs, head and neck cancer, and others. The large-scale investment in research and development for cancer treatment all around the world, the increasing number of cancer cases, and the demand for non-invasive treatment procedures are a few of the factors driving the radiotherapy market all over the world. Although, the lack of ability of radiotherapy for the metastasis state cancer treatment, side effects, availability of other alternative therapies are a few of the factors being restrains in the global radiotherapy market.

Global Radiotherapy Market drivers:

  • Technological Advancement in radiotherapy devices:

The last few decades have encountered significant technological growth in the medical field. Advancements in radiotherapy devices also took place during the same period and are showing steady growth. Technological advancements have helped in the provision of low-cost, easy-to-use, and more effective radiotherapy devices. These devices or radiotherapy products are available with precise and improved radiation dose delivery that offers more efficiency in targeting tumors. Many radiotherapy devices got updated to 3D from 2D which has enabled high-quality conformity of radiation with real-time imaging of a target tumor. This has also escalated dose with improved tumor control. Due to the significant successful results for cancer patients, the demand for such advanced devices has been increasing. This has also led to the continuous research and development in the introduction of new radiotherapy techniques, devices, or products.

Many of the radiotherapy sessions take around 30 minutes in duration which is one of the reasons cancer patients prefer radiotherapy or radiation therapy over other cancer treatments. The target-specific treatment of radiotherapy is another reason for its rising demand. For instance, External Beam radiotherapy uses three types of particles, they are Photon, Proton, and Electrons. External beam radiotherapy is a local treatment, which means the particles or beams used by the machines target the specific part of the body leaving the other parts or tissues unaffected to a certain extent. Especially the Proton beams in the external radiotherapy machine, do no scatter while reaching the targeted part that is the tumor, and it stops once reached the tumor part. Hence, the Proton particles do not affect the other parts and the parts or tissue in the path of the beam.

Whereas Internal radiotherapy also called Brachytherapy is more often preferred to treat breast, head, neck cancer, and other cancers as well. It involves the delivery of a high dose of radiation from inside the body with comparatively fewer side effects. Such the advantages of radiotherapy devices, the introduction of a highly advanced alternative to other cancer treatments, and rising knowledge about radiotherapy among patients and healthcare professionals around the world, the demand for radiation therapy are rising globally. Furthermore, the large-scale investment by various institutes, governments around the world in research and development in Oncology, has encouraged the experts to make innovations and advancements in the radiotherapy field.

In addition to this, the increasing cases of cancer around the world are another factor influencing the growing demand for radiotherapy in the last few years. For instance, the Centers for Disease Control and Prevention have reported that in the year 2018 the number of cancer cases was increased to 17,08,921. Whereas according to the American Cancer Society Journal, scientific research on facts and figures of cancer estimated that there will be around 1.9 billion new cancer cases in America and around 609,360 deaths due to cancer. The changing lifestyle, changes in diet, and many more are the reason behind the increasing number of cancer cases in developed and developing countries. Moreover, rise in per capita income and increasing awareness about the medical facilities, the inclination towards regular medical checkups is rising which can help both the patient and healthcare professionals for the early diagnosis of diseases like cancer. In March 2021, WHO and International Atomic Energy Agency (IAEA) guided the radiotherapy equipment. The report also suggests that radiotherapy is required by more than 50% of cancer patients. These factors are expected to robust the radiotherapy market during the forecast period.

Global Radiotherapy Market Restraints

Although the increasing awareness regarding radiotherapy, several patients around the world even at the present prefer other alternative cancer treatments. Moreover, the devices used in radiotherapy are larger and require a large space for installation, hence due to lack of improved healthcare infrastructure due to the limited expenditure on healthcare in many developing and underdeveloped countries is one of the factors being an obstacle for the adoption of radiotherapy system. Furthermore, as radiotherapy is used to directly treat the targeted area, it is difficult to treat cancer in a metastasis state. This can lead to doubting the appearance of cancer in the future. In addition to this, many patients also experience various side effects of the radiotherapy such as skin rashes, effects on other tissues in the path of photons beam exerted by the External beam radiotherapy machines, and many more. These all factors are expected to hinder the radiotherapy market growth worldwide.

Latest developments

Considering the growing awareness regarding radiotherapy and the increasing number of cancer cases worldwide, many key market players also have focused on the development, launch, and approval of advanced radiotherapy products. For instance, Sweden-based company Elekta 2020, introduced a cancer treatment system Elekta Harmony linear accelerator. This new system has a shorter treatment slot of around 25% and a footprint of 30% smaller. Whereas, in the same year ALCEN group’s subsidiary PMB launched a FLASH radiotherapy system, FLASHKNiFE which was dedicated to clinical trials. In January 2022, Ion Beam Application announced the launch of Cyclone Key, a new low-energy machine with a compact size cyclotron. The company reports that this new machine will enable hospitals of small and medium-size to produce hospitals’ radiopharmaceutical products this provide global access for the diagnostic solutions in oncology.

Regional analysis

Many Asian countries like India, China, Japan, Malaysia, and others have shown a rise in the number of cancer cases in recent years. Furthermore, the Asia-pacific region contributes to more than 50% of cancer cases in the world. In addition to these factors, the rise in per capita income, growing literacy rate has paved way for growing awareness regarding regular medical checkups, and knowledge about cancer treatments like radiotherapy is growing in this region. Due to these factors, the radiotherapy market share of the Asia-Pacific region is expected to grow during the forecast period. The market share of the Asia-Pacific region was valued at US$ XX billion in the year 2019 and is expected to reach up to US$ XX billion in the year 2026.

Impact of COVID-19 on Radiotherapy Market

A sudden outbreak of COVID-19 has affected several sectors such as industrial, sales, suppliers, and many more. It also affected the medical device industry, which includes radiotherapy devices as well. Because of the widespread scare of lockdown during the year 2020, the global radiation oncology sites faced an immense downturn. Due to the increasing threat of Covid-19, patients preferred staying at home to reduce the exposure. This restriction in the movements affected the treatment and diagnosis process as well. While research by the University of Leeds WITH Royal College of Radiologists and Public Health England reported that there was seen a decline in radiotherapy treatment courses by 19.9% in April 2020, 6.2% in May, and 11.6% in June in the year 2020. The research also mentioned that the large use of hypofractionated dosing in England helped radiation oncology sites to deliver radiotherapy during the COVID-19 period.

Radiotherapy Market Scope:

Report Metric Details
 Market size value in 2019  US$8.058 billion
 Market size value in 2026  US$13.861 billion
 Growth Rate  CAGR of 8.06% from 2019 to 2026
 Base year  2019
 Forecast period  2021–2026
 Forecast Unit (Value)  USD Billion
 Segments covered  Therapy Type, Application, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Elekta AB, Accuray Incorporated, Ion Beam Applications (IBA), Isoray Medical, Inc., Canon Medical Systems Corporation, Mirada Medical, Eckert & Ziegler, Siemens Healthineers, Varian Medical Systems, Inc, Mevion Medical Systems, Inc.
 Customization scope  Free report customization with purchase



  • By Therapy type
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/Brachytherapy
    • Systemic Radiotherapy
  • By Application
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head And Neck Cancer
    • Others
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centres
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Others
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for the radiotherapy market?
A1. The global radiotherapy market is projected to grow at a CAGR of 8.06% during the forecast period.

Q2. What is the size of the global radiotherapy market?
A2. Radiotherapy Market was valued at US$8.058 billion in 2019.

Q3. What will be the radiotherapy market size by 2026?
A3. The radiotherapy market is projected to reach a market size of US$13.861 billion by 2026.

Q4. What factors are anticipated to drive the radiotherapy market growth?
A4. The rising number of cancer patients around the world has paved the way for increasing demand for the radiotherapy market.

Q5. Which region holds the largest market share in the radiotherapy market?
A5. Asia Pacific region is expected to grow at a significant pace in the radiotherapy market during the forecast period.

1.1. Market Definition
1.2. Market Segmentation

2.1. Research Data
2.2. Assumptions

3.1. Research Highlights

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5.1. Introduction
5.2. External Beam Radiotherapy
5.3. Internal Beam Radiotherapy/Brachytherapy
5.4. Systemic Radiotherapy 

6.1. Introduction
6.2. Prostate Cancer
6.3. Breast Cancer
6.4. Lung Cancer
6.5. Head And Neck Cancer
6.6. Others 

7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centres
7.4. Others 

8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. UK
8.4.4. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others

9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10.1. Elekta AB
10.2. Accuray Incorporated
10.3. Ion Beam Applications (IBA)
10.4. Isoray Medical, Inc.
10.5. Canon Medical Systems Corporation
10.6. Mirada Medical
10.7. Eckert & Ziegler
10.8. Siemens Healthineers
10.9. Varian Medical Systems, Inc
10.10. Mevion Medical Systems, Inc.

Elekta AB

Accuray Incorporated

Ion Beam Applications (IBA)

Isoray Medical, Inc.

Canon Medical Systems Corporation

Mirada Medical

Eckert & Ziegler

Siemens Healthineers

Varian Medical Systems, Inc

Mevion Medical Systems, Inc.